Cellular relocalisation of protein kinase C-Θ caused by staurosporme and some of its analogues

Biochemical Pharmacology

Volumn 53, Issue 10, 1997, Pages 1413-1418

  Jones, Tony A ^a   Courage, Carol ^a   Hubbard, Andy ^a   Gescher, Andreas ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Bisindolylmaleimides; Protein kinase C translocation; Staurosporine

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 7 HYDROXYSTAUROSPORINE; BISINDOLYLMALEIMIDE; MIDOSTAURIN; PHORBOL ESTER DERIVATIVE; PROTEIN KINASE C; STAUROSPORINE;

ARTICLE; CARCINOMA CELL; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; LUNG CARCINOMA; PRIORITY JOURNAL;

ALKALOIDS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL MEMBRANE; CELL NUCLEUS; CYTOSOL; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; INDOLES; ISOENZYMES; MALEIMIDES; MICROSCOPY, CONFOCAL; MODELS, CHEMICAL; PROTEIN KINASE C; STAUROSPORINE; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED; ZINC FINGERS;

EID: 0030872696     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00863-5     Document Type: Article

References (23)

1. Nishizuka Y, Intracellular signaling by hydrolysis of phospholipids and activation of PKC. Science 258: 607-614, 1992.
2. Borner C and Fabbro D, PKC and cellular transformation. In: Protein Kinase C - Current Concepts and Future Perspectives. (Eds. Lester DS, Epand R), pp. 297-354. Ellis Horwood Ltd, Chichester, 1992.
3. Jaken S, Protein kinase C isozymes and substrates. Curr Opin Cell Biol 8: 168-173, 1996.
4. Yoshizawa S, Fujiki H, Suguri H, Suganuma M, Nakayasu M, Matsushimna R and Sugimura T, Tumor-promoting activity of staurosporine, a protein kinase inhibitor, in mouse skin. Cancer Res 50: 4974-4978, 1990.
5. Yamada S, Hirota K, Chida K and Kuroki T, Inhibition of phorbol ester-caused induction of ornithine decarboxylase and tumor promotion in mouse skin by staurosporine, potent inhibitor of protein kinase C. Biochem Biophys Res Commun 157: 9-15, 1988.
6. Sako T, Tauber AI, Jeng AY, Yuspa SH and Blumberg PM, Contrasting actions of staurosporine, a protein kinase C inhibitor, on human neutrophils and primary mouse epidermal cells. Cancer Res 48: 4646-4650, 1988.
7. Dlugosz AA and Yuspa SH, Staurosporine induces protein kinase-C agonist effects and maturation of normal and neoplastic mouse keratinocytes in vitro. Cancer Res 51: 4671-4684, 1991.
8. Kiley SC, Parker PJ, Fabbro D and Jaken S, Selective redistribution of protein kinase C isozymes by thapsigargin and staurosporine. Carcinogenesis 13: 1997-2001, 1992.
9. Tamaoki T and Nakano H, Potent and specific inhibitors of protein kinase C of microbial origin. Biotechnology 8: 732-735, 1990.
10. Meyer T, Regenass U, Fabbro D, Alteri E, Rösel J, Müller M, Caravatti G and Matter A, A derivative of staurosporine (CGP 41251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vitro antitumour activity. Int J Cancer 43: 851-856, 1989.
11. Akinaga S, Gomi K, Morimoto M, Tamaoki T, and Okabe M, Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models. Cancer Res 51: 4888-4892, 1991.
12. Courage C, Budworth J, Gescher A, Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation. Br J Cancer 71: 697-704, 1995.
13. Chang JD, Xu Y, Raychowdhury MK and Ware JA, Molecular cloning and expression of a cDNA encoding a novel isoenzyme of protein kinase C (nPKC). J Biol Chem 268: 14208-14214, 1993.
14. Baier G, Baier-Bitterlich G, Meller N, Coggeshall KM, Giampa L, Telford D, Isakov N and Altman A, Expression and biochemical characterisation of human protein kinase C-θ. Eur J Biochem 225: 195-203, 1994.
15. Baier G, Telford D, Giampa L, Coggeshall KM, Baier-Bitterlich G, Isakov N and Altman A, Molecular cloning and characterization of PKC-θ, a novel member of the protein kinase C (PKC) family expressed predominantly in hematopoietic cells. J Biol Chem 268: 4997-5004, 1993.
16. Greif H, Ben-Chaim J, Shimon T, Bechor E, Eldar H and Livneh E, The protein kinase C related PKC-L (η) gene product is localized in the cell nucleus. Mol Cell Biochem 12: 1304-1311, 1992.
17. Stanwell C, Gescher A, Bradshaw TD and Pettit GR, The role of protein kinase C isoenzymes in growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells. Int J Cancer 56: 585-592, 1994.
18. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
19. Davis PD, Elliott L, Harris W, Hurst SA, Keech E, Kumar H, Lawton G, Nixon JS and Wilkinson SE, Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity. J Med Chem 35: 994-1001, 1992.
20. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D and Kirilovsky J, The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266: 15771-15781, 1991.
21. Wilkinson SE, Parker PJ and Nixon JS, Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J 294: 335-337, 1993.
22. Seynaeve CM, Kazanietz MG, Blumberg PM, Sausville EA and Worland PJ, Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue. Mol Pharmacol 45: 1207-1214, 1994.
23. Mochly-Rosen D, Khaner H, Lopez J and Smith BL, Intracellular receptors for activated protein kinase C. J Biol Chem 266: 14866-14868, 1991.